## Clinical Diagnosis and Management Strategy **Key Point:** This patient has classic plaque psoriasis (chronic, localized, well-demarcated lesions with positive Auspitz sign). The diagnosis is clinical and does not require histopathology confirmation in straightforward cases. ### Rationale for Correct Answer For mild-to-moderate localized plaque psoriasis without systemic involvement: 1. **Topical therapy is first-line** — Potent topical corticosteroids (Class II–III) combined with emollients are the standard initial approach for limited body surface area involvement. 2. **Counseling on triggers** — Stress, infection, trauma, and certain drugs (lithium, NSAIDs, beta-blockers) are known precipitants; patient education reduces relapse risk. 3. **No systemic features** — Absence of arthralgia, nail involvement, or extensive disease does not warrant systemic agents or specialist referral at this stage. ### Management Algorithm for Plaque Psoriasis ```mermaid flowchart TD A[Plaque psoriasis diagnosed clinically]:::outcome --> B{Body Surface Area affected?}:::decision B -->|< 10% BSA| C[Topical corticosteroids + emollients]:::action B -->|10-30% BSA| D[Topical therapy ± phototherapy]:::action B -->|> 30% BSA or systemic features| E[Consider systemic agents]:::action C --> F[Counsel on triggers & lifestyle]:::action D --> F E --> G[Methotrexate, acitretin, or biologics]:::action F --> H[Review at 4-6 weeks]:::action ``` **High-Yield:** Plaque psoriasis is a **clinical diagnosis**; biopsy is reserved for atypical presentations or diagnostic uncertainty, not routine cases. **Clinical Pearl:** Auspitz sign (pinpoint bleeding after gentle scale removal) and Koebner phenomenon (lesions at sites of trauma) are hallmark features that support the diagnosis without need for biopsy. ## Why Topical Therapy Works Here | Feature | Implication | |---------|-------------| | Localized lesions (elbows, knees, scalp) | Topical agents penetrate well; systemic therapy unnecessary | | No arthralgia or nail dystrophy | No evidence of systemic/arthritic disease | | 6-month duration | Chronic plaque type; not acute pustular or erythrodermic | | Negative serology | Rules out secondary causes; primary psoriasis confirmed | 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.